FDA authorises marketing of device to improve gait in multiple sclerosis patients

26 March 2021 - Today, the U.S. FDA authorised marketing of a new device indicated for use as a short-term treatment ...

Read more →

FDA approves first in the world device to treat patients with congenital heart disease

26 March 2021 - New implant device provides less invasive option to treat pulmonary valve regurgitation for patients with a native ...

Read more →

FDA grants two new breakthrough device designations for Natera’s Signatera MRD test

24 March 2021 - Natera today announced that the US FDA has granted two breakthrough device designations covering new intended ...

Read more →

FDA grants breakthrough device designation to Tempus’ atrial fibrillation ECG analysis platform, developed in collaboration with Geisinger

24 March 2021 - Tempus today announced that the U.S. FDA has granted the company breakthrough device designation for its ECG ...

Read more →

Stimdia Medical receives FDA breakthrough device designation for the pdSTIM system designed to facilitate weaning patients from mechanical ventilation

18 March 2021 - Stimdia Medical today announced the company’s pdSTIM system has received breakthrough device designation from the U.S. FDA. ...

Read more →

Sparta Biomedical receives FDA breakthrough device designation for SBM-01 biomimetic implant

17 March 2021 - Sparta Biomedical today announced that its SBM-01 biomimetic implant has been granted a breakthrough device designation from ...

Read more →

Leveraging real world evidence in regulatory submissions of medical devices

16 March 2021 - Among the many ways that the U.S. FDA protects and promotes the public health is by ensuring ...

Read more →

Revolutionary option for medical device sterilisation approved by FDA

11 March 2021 - The United States FDA newly approved chlorine dioxide gas for contract sterilisation of medical devices.  ...

Read more →

Berlin Heals receives breakthrough device designation from FDA for its C-MIC heart failure device and initiates early feasibility study in the United States

11 March 2021 - Berlin Heals announced today that the US FDA has granted a breakthrough device designation for its ...

Read more →

FDA grants breakthrough device designation for Inivata’s RaDaR assay

9 March 2021 - Designation will help accelerate the regulatory path of RaDaR for use in detection of minimal residual ...

Read more →

U.S. FDA accepts UVision360 submission for novel Luminelle DTx system biopsy sheath

9 March 2021 - UVision360 announces today that the U.S. FDA has accepted the Company's submission to expand the Luminelle DTx ...

Read more →

FDA approves Accu-Joint hemi implant, a hemi-arthroplasty metatarsal head or phalangeal base implant for the metatarsophalangeal joint

2 March 2021 - The Accu-Joint is indicated for use in the treatment of patients with degenerative and post-traumatic arthritis in ...

Read more →

MedAlliance receives fourth FDA breakthrough device designation for sirolimus drug eluting balloon in treatment of de novo coronary lesions

4 March 2021 - MedAlliance has now been awarded breakthrough status for SELUTION SLR, its sustained limus release DEB catheter, in ...

Read more →

FDA grants de novo to ML-based, real-time indicator of patient deterioration

2 March 2021 - Fifth Eye's non-invasive tool is the first to provide continuous monitoring of haemodynamic status using a single ...

Read more →

Relivion wearable brain neuromodulation technology cleared by FDA for the treatment of migraine

2 March 2021 - Relivion is the only non-invasive multi-channel neuromodulation technology for the treatment of acute migraine. ...

Read more →